Marapharm Ventures Inc. (CSE: MDM) (OTXQX: MRPHF) (FSE: 2M0) (“Marapharm” or the “Company”) announces that the final plans for the Company’s first cultivation facility in Desert Hot Springs, California are complete and ready for submission to the City.
The Company engaged MSA Consulting Inc. (www.msaconsultinginc.com) a premier Civil Engineering, Planning and Surveying firm. They collaborated with our Director of Operations to design and execute the fully engineered architectural plans, in preparation for the final Local Planning Department approval. This will allow the Company to “break ground” in early August 2018.
The project is approved with a Conditional Use Permit for cannabis cultivation, processing and extraction. The first floor will include 9,175 sq.ft. of indoor grow, 2,036 sq.ft of processing/extraction and 1,391 sq.ft. of office space. The second floor with include 12,782 sq.ft of indoor grow. The total cultivation space of this facility is 21, 957 sq.ft.
Marapharm will use “rolling greenhouse tables” to eliminate the need for dedicated aisles. This will allow us to maximize our canopy space and produce approximately 9,000 pounds of flower annually, plus ancillary products from the processing facility.
The 720 High-intensity discharge lights (HID) will be supplied by Solis Tek Digital Lighting www.solis-tek.com, an industry leader focused on the research, design, development and manufacturing of advanced & efficient lighting products.
We have selected PRIVA to provide irrigation and disinfection systems to be installed in both our Washington and California facilities. PRIVA, is based in Holland and is the world leader in Horticultural design, automation and control. It will deliver an irrigation and disinfection system that allows for automation of nutrient delivery and a 98% capture of all water in the facility for re-use, including irrigation run-off and condensate water from all HVAC equipment.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm’s ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm’s business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm’s website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD – LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward- looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.